Betamethasone to help premature babies off breathing support
Treatments studied
Part of Genetic & congenital, Lungs & breathing clinical trials.
This trial tests whether a steroid called betamethasone, given after birth, helps extremely premature babies (born before 28 weeks) come off breathing support safely. It aims to make weaning from a ventilator quicker and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born before 28 weeks of pregnancy
- Admitted to the NICU before reaching day 35 of life
- No major birth defects or chromosome problems
- Survived past the first week of life (after day 7)
- Never received steroids after birth
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a steroid medicine called dexamethasone can help prevent a serious lung problem in very premature babies who need a breathing machine for a long time. It may help babies who are still on the machine after two weeks and need high levels of oxygen.
This study looks at whether a careful CPAP breathing support plan helps very premature babies breathe better. It may be an option for babies who are stable on low oxygen settings and have few breathing pauses.
This study tests whether a low dose of a steroid medicine given to pregnant people late in pregnancy can help a baby’s lungs if delivery happens early. If you’re due for late-preterm delivery soon, the trial may help reduce breathing problems in the newborn.
This study checks whether giving a lower dose of a steroid medicine (betamethasone) to mothers before birth produces similar brain and thinking outcomes in children born very early (before 32 weeks). It may help reduce medicine exposure while keeping developmental results the same.
This trial tests a new treatment to help very premature babies (born at 22 to nearly 29 weeks) who still need a breathing machine and extra oxygen at 1–2 weeks old. The goal is to see if it can improve their lung health and reduce the need for breathing support.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
Hear when a new Bronchopulmonary Dysplasia (BPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.